It is estimated that the necrobiosis lipoidica diabeticorum (NLD) market would be worth US$ 4.5 billion in 2023 and US$ 8.06 billion in 2033, with a compound annual growth rate (CAGR) of 6% between 2023 and 2033. Necrobiosis Lipoidica Diabeticorum (NLD) developed at a compound annual growth rate of 4% between 2017 and 2022. Necrobiosis …